| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Chief Executive Officer | Director +2 more
6 companies
Tang Kevin is a Chief Executive Officer at AUPH, with reported holdings spanning 6 companies. Recent filings cover 79 purchases and 19 sales. Those positions are worth an estimated $335.3M at current prices.
Our model assigns Tang Kevin a strong insider score of 85/100, based on 13 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +64.7%.
Tang Kevin's largest disclosed position is in AUPH as Chief Executive Officer, worth about $199.3M. Net of sales, the recent Form 4 record there shows accumulation of 5,814,606 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 149,474 | $2.34 | $349,592.97 | +5.3% | - | - | |
| Aug 26, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Sell | 18,300 | $2.97 | $54,351.00 | -0.6% | - | - | |
| Jul 21, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 4,863 | $2.44 | $11,865.72 | +0.2% | -6.9% | - | |
| Jul 17, 2026 | FULC Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 167,616 | $3.55 | $594,675.16 | +2.4% | +0.5% | - | |
| Jul 16, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 63,969 | $2.43 | $155,645.58 | +2.3% | -4.0% | - | |
| Jul 15, 2026 | FULC Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 249,946 | $3.57 | $891,067.48 | +3.8% | +3.4% | - | |
| Jul 13, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 91,585 | $2.42 | $222,069.79 | +3.4% | +4.5% | - | |
| Jul 8, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 57,210 | $2.48 | $141,864.66 | +2.2% | +4.9% | - | |
| Jul 2, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 107,463 | $2.50 | $268,880.37 | +4.2% | +0.4% | - | |
| Jun 29, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 286,333 | $2.50 | $714,768.12 | +12.7% | +6.5% | - |